SMO and breast cancer: Specifically, the role of canonical, SMO-/SHH-dependent HH signaling [13,14] and non-canonical, SMO-/SHH-independent HH signaling [15,16] was addressed, as this pathway has been linked to tumorigenesis including breast cancer [17,18,19].